AVXL on Nasdaq

ANAVEX LIFE SCIENCES CORP.

Price unavailable

Last updated Oct 16, 2026.

Overview

-$46.4MNet income, fiscal 20252

Compare with another stock.

  • TickerAVXL on Nasdaq
  • IndustryBiological Products, (No Diagnostic Substances)
  • Business address630 5Th Avenue, 20Th Floor, New York, Ny 101113
  • Filer categoryLarge accelerated filer, Smaller reporting company3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

-48.9%Return on equity2

Financial statements

Operating income452-$51.4M in 2025+65% since 2020
-$60.0M-$40.0M-$20.0M02020: -$31.1M-$31.1M20202021: -$42.0M-$42.0M2021+35%2022: -$51.0M-$51.0M2022+21%2023: -$55.8M-$55.8M2023+9%2024: -$52.9M-$52.9M2024−5%2025: -$51.4M-$51.4M2025−3%
Net income67452-$46.4M in 2025+169% since 2018
-$60.0M-$40.0M-$20.0M02018: -$17.3M-$17.3M20182019: -$26.3M-$26.3M2019+52%2020: -$26.3M-$26.3M2020−0%2021: -$37.9M-$37.9M2021+44%2022: -$48.0M-$48.0M2022+27%2023: -$47.5M-$47.5M2023−1%2024: -$43.0M-$43.0M2024−9%2025: -$46.4M-$46.4M2025+8%

Every line of the income statement in the latest annual report, as filed.2

Period ending2025-09-302024-09-302023-09-30
General and administrative$13.8M$11.0M$12.0M
Research and development$37.6M$41.8M$43.7M
Total operating expenses$51.4M$52.9M$55.8M
Operating loss-$51.4M-$52.9M-$55.8M
Grant income$37.0K$75.0K$25.0K
Research and development incentive income$648.0K$2.3M$2.7M
Interest income, net$4.7M$7.3M$6.5M
Other financing expense-$964.0K
Foreign exchange gain (loss)-$332.0K$189.0K-$40.0K
Total other income, net$5.0M$9.9M$8.3M
Net loss and comprehensive loss-$46.4M-$43.0M-$47.5M
Net Loss per share, Basic-$0.54-$0.52-$0.60
Net Loss per share, Diluted-$0.54-$0.52-$0.60
Weighted average number of shares outstanding, Basic85.3M shares83.5M shares79.8M shares
Weighted average number of shares outstanding, Diluted85.3M shares83.5M shares79.8M shares

Compare ANAVEX LIFE SCIENCES CORP. with another company

Former names

  • Thrifty Printing Inc.Jan 13, 2005 to Jan 25, 20073

Recent filings

  1. Oct 5, 20263
  2. Oct 5, 20263
  3. Sep 28, 20268-K
  4. Sep 28, 20264
  5. Sep 21, 2026DFAN14A
  6. Sep 18, 2026DFAN14A
  7. Sep 17, 2026DFAN14A
  8. Sep 15, 2026DFAN14A
  9. Sep 15, 2026DEFA14A
  10. Sep 14, 2026DEFA14A
  11. Sep 10, 2026DFAN14A
  12. Sep 10, 2026DFAN14A
  13. Sep 9, 20268-K
  14. Sep 9, 2026DFAN14A
  15. Sep 8, 2026DEFA14A

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1